The AVANZA Advisory Board - Scientific and Regulatory

 

Kory Engelke, Ph. D., D.A.B.T.

 

Dr. Engelke received his PhD in Pharmacology and BS in Biochemical Sciences from the University of Vermont and is a Diplomate of the American Board of Toxicology.. He is a member of the Society of Toxicology and American College of Toxicology. Dr. Engelke has experience in the drug development industry in the pharmaceutical and contract research sectors dating back to the 1990s. He is able to utilize his previous experience on multidisciplinary drug development teams to successfully design, monitor, submit, and defend preclinical sections of worldwide regulatory documents in support of clinical development. Prior roles include Executive Director of Product Development and Consulting Services at AVANZA Laboratories, Executive Director of Toxicology Services at Bridge Laboratories, Senior Director of Toxicology at Gene Logic Laboratories, Study Director at Battelle Memorial Institute, and several senior scientific roles at Sucampo Pharmaceuticals and Guilford Pharmaceuticals. He was responsible for the successful submission, defense, and label negotiation of an approved marketed product. Dr. Engelke is currently part of the Parexel Consulting team of professionals focusing on clinical development.

 

Return to the Advisory Board - Scientific and Regulatory members